Here we suggest that this vicious cycle can be reversed through antagonizing ERRα activity given that inhibition of ERRα decreases blood insulin levels, increases insulin sensitivity and protects animals from HFD-induced fatty liver (88, 100, 114). Here, ESRRA is linked to fatty liver disease.